Research analysts at StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR – Get Free Report) in a report issued on Tuesday. The firm set a “sell” rating on the medical device company’s stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback